Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • HL celebrates
    Black History Month

  • Register
  • Help
  • Contact us
  • Log in to HL Account

Quanterix Corp (QTRX) USD0.001

Sell:$33.90 Buy:$33.99 Change: $0.13 (0.39%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.13 (0.39%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.13 (0.39%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Quanterix Corporation develops ultra-sensitive digital immunoassay platform and tools for life science research and diagnostics. The Company offers single molecule array (Simoa) platform, which uses single molecule measurements to detect protein biomarkers. The Company is also focusing to enable and develop novel therapies and diagnostics to facilitate in healthcare for earlier detection, monitoring, prognosis and, ultimately, prevention of disease. Simoa focuses on research and clinical testing applications and significantly advances enzyme-linked immunosorbent assay (ELISA) technology which is capable of unprecedented protein detection sensitivity. It also focuses on research and diagnostics for brain injuries, heart disease, cancer and other infectious diseases with its technology. The Company offers Simoa HD-1 analyzer, which is an automated immunoassay platform with multiplexing and custom assay capability.

Contact details

900 Middlesex Tpke
United States
+1 (617) 3019400

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$1.06 billion
Shares in issue:
31.43 million
Life Sciences Tools & Services
United States
US dollar

Key personnel

  • E. Kevin Hrusovsky
    Chairman of the Board, President, Chief Executive Officer
  • Amol Chaubal
    Chief Financial Officer
  • David Duffy
    Senior Vice President, Research & Development and Chief Technology Officer
  • Dawn Mattoon
    Senior Vice President - Research Products
  • Mark Roskey
    Senior Vice President - Commercial and Accelerator
  • John Fry
    General Counsel, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.